Skip to content
★ Sign in to follow
RK

Ravindra Kumar

Acceleron Pharma Inc
Total declarations
99
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (57 ops.)
€6.1M

Latest filing published 10 Sept 2019 for Acceleron Pharma INC, €139k.

Filing timeline

BuySale
Ravindra Kumar

Insider track record

Disclosed buys
0
Disclosed sells
57
Signal history

Ravindra Kumar: trading record in brief

This profile gathers the share dealings of Ravindra Kumar in Acceleron Pharma Inc. The record holds 99 filings, for trades running from 22 April 2014 to 10 September 2019.

No open-market purchase appears, only 57 sales worth €6.1M. Besides market trades, the filings include 5 share grants and 37 option exercises. Since January 2019: no purchases and 7 sales on the market.

On 10 September 2019 came the latest disclosure, an open-market sale for €139k in Acceleron Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ravindra Kumar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations99 total
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    153,318 USD32SEC
    3,389 shares@ US$45.2425.9% of flowCommon StockSEC:0001179110-19-010222:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    3,097 USD29SEC
    70 shares@ US$44.240.4% of flowCommon StockSEC:0001179110-19-004913:2
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    154,028 USD31SEC
    3,452 shares@ US$44.6219.9% of flowCommon StockSEC:0001179110-19-004913:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    4,546 USD29SEC
    100 shares@ US$45.460.6% of flowCommon StockSEC:0001179110-19-004913:1
  • ◆
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    0SEC
    3,850 shares0Common StockSEC:0001179110-19-001057:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    100,309 USD30SEC
    2,363 shares@ US$42.4512.7% of flowCommon StockSEC:0001179110-19-000470:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    131,803 USD31SEC
    3,051 shares@ US$43.2016.7% of flowCommon StockSEC:0001179110-19-000470:1
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    16,434 USD29SEC
    374 shares@ US$43.942.1% of flowCommon StockSEC:0001179110-19-000470:2
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    42,289 USD29SEC
    1,103 shares@ US$38.340.9% of flowCommon StockSEC:0001179110-18-005399:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    3,916 USD29SEC
    100 shares@ US$39.160.1% of flowCommon StockSEC:0001179110-18-005399:1
  • ◆
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    0SEC
    4,463 shares0Common StockSEC:0001179110-18-003498:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    182,363 USD29SEC
    4,300 shares@ US$42.414.0% of flowCommon StockSEC:0001179110-18-000548:0
  • ◇
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    35,698 USD11SEC
    6,761 shares@ US$5.280.8% of flowCommon StockSEC:0001179110-17-012763:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    176,418 USD29SEC
    4,605 shares@ US$38.313.8% of flowCommon StockSEC:0001179110-17-012290:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    19,695 USD29SEC
    500 shares@ US$39.390.4% of flowCommon StockSEC:0001179110-17-012290:1
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    305 USD29SEC
    8 shares@ US$38.120.0% of flowCommon StockSEC:0001179110-17-012290:2
  • ◇
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    314,997 USD12SEC
    13,065 shares@ US$24.117.0% of flowCommon StockSEC:0001179110-17-011284:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    462,632 USD12SEC
    13,065 shares@ US$35.4110.2% of flowCommon StockSEC:0001179110-17-011284:1
  • ◇
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    6,671 USD11SEC
    937 shares@ US$7.120.2% of flowCommon StockSEC:0001179110-17-010227:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    29,984 USD26SEC
    937 shares@ US$32.000.7% of flowCommon StockSEC:0001179110-17-010227:1
  • ◆
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    0SEC
    6,900 shares0Common StockSEC:0001179110-17-004592:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    9,625 USD29SEC
    359 shares@ US$26.810.2% of flowCommon StockSEC:0001179110-17-000684:0
  • ▼
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    45,292 USD29SEC
    1,641 shares@ US$27.601.1% of flowCommon StockSEC:0001179110-17-000684:1
  • ◇
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    52,800 USD11SEC
    10,000 shares@ US$5.281.3% of flowCommon StockSEC:0001179110-16-033441:0
  • ◇
    SVP & Chief Scientific OfficerExecutivesAcceleron Pharma Inc
    17,697 USD11SEC
    4,561 shares@ US$3.880.4% of flowCommon StockSEC:0001179110-16-033441:1

25 of 99 declarations